Sera Prognostics (SERA) Files 8-K

Ticker: SERA · Form: 8-K · Filed: Jan 31, 2025 · CIK: 1534969

Sentiment: neutral

Topics: corporate-filing, 8-k

Related Tickers: SERA

TL;DR

SERA filed a standard 8-K confirming its address and Nasdaq listing.

AI Summary

On January 31, 2025, Sera Prognostics, Inc. (SERA) filed a Form 8-K to report its current status. The filing confirms the company's principal executive offices are located at 2749 East Parleys Way, Suite 200, Salt Lake City, Utah, 84109, and its telephone number is (801) 990-0520. Sera Prognostics, Inc. is incorporated in Delaware and its Class A Common Stock is traded on The Nasdaq Stock Market LLC under the symbol SERA.

Why It Matters

This 8-K filing serves as a standard corporate update, confirming Sera Prognostics' operational details and stock exchange listing, which is important for investors tracking the company's official disclosures.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain any new material information that would significantly alter the company's risk profile.

Key Players & Entities

FAQ

What is the primary purpose of this Form 8-K filing for Sera Prognostics, Inc.?

The primary purpose of this Form 8-K filing is to report current information as required by the Securities Exchange Act of 1934, specifically confirming the company's principal executive offices, telephone number, and stock exchange listing.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on January 31, 2025.

Where are Sera Prognostics, Inc.'s principal executive offices located?

Sera Prognostics, Inc.'s principal executive offices are located at 2749 East Parleys Way, Suite 200, Salt Lake City, Utah, 84109.

On which stock exchange is Sera Prognostics, Inc.'s Class A Common Stock traded?

Sera Prognostics, Inc.'s Class A Common Stock is traded on The Nasdaq Stock Market LLC.

What is the trading symbol for Sera Prognostics, Inc. on The Nasdaq Stock Market LLC?

The trading symbol for Sera Prognostics, Inc. on The Nasdaq Stock Market LLC is SERA.

Filing Stats: 1,692 words · 7 min read · ~6 pages · Grade level 14.3 · Accepted 2025-01-31 13:31:30

Key Financial Figures

Filing Documents

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This Report contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the future use of PreTRM based on the PRIME study results, statements about the Company's expectations that the PreTRM Test has the potential to address a significant unmet need, and statements regarding the Company's cash, cash equivalents and marketable securities as of December 31, 2024. These "forward-looking statements" are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by forward-looking statements. These risks and uncertainties include, but are not limited to: the need for broad scientific and market acceptance of the PreTRM Test; a concentrated number of material customers; the Company's ability to introduce new products; potential competition; the Company's proprietary biobank; the availability of critical suppliers; estimates of total addressable market opportunity and forecasts of market growth; potential third-party payer coverage and reimbursement; new reimbursement methodologies applicable to the PreTRM Test, including new CPT codes and payment rates for those codes; changes in U.S. Food and Drug Administration regulation of laboratory-developed tests; the intellectual property rights protecting the Company's tests and market position; and other factors discussed under the heading "Risk Factors" contained in the Company's Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on March 20, 2024, as well as any updates to those risk factors filed from time to time in the Company's Quarterly Reports on Form 10-Q, or Current Reports on Form 8-K. All information in this Report is as of the date of the Report, and the Company undertakes no duty to update this information u

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SERA PROGNOSTICS, INC. Date: January 31, 2025 By: /s/ Austin Aerts Austin Aerts Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing